const storiesData = {
  covishield: [
    {
      title: "What is covishield?",
      image: `${process.env.REACT_APP_CLOUDINARY_URL}/Covishield_vthloa.jpg`,
      text: `The Oxford–AstraZeneca COVID-19 vaccine, codenamed AZD1222, is sold under the brand names Covishield in India. It was developed by Oxford University and AstraZeneca and currently manufactured by Serum Institute of India. The medicine is administered by two 0.5 ml doses injected intramuscularly into the deltoid muscle (upper arm) four to twelve weeks apart.`,
      bgColor: "#2196F3",
      type: "titleImageTextPost",
    },
    {
      title: "How it works?",
      image: `${process.env.REACT_APP_CLOUDINARY_URL}/Covishield2_cpezg7.jpg`,
      text: `The vaccine is made from a weakened version of a common cold virus (known as an adenovirus) from chimpanzees. It has been modified to look more like coronavirus - although it can't cause illness. When the vaccine is injected into a patient, it prompts the immune system to start making antibodies and primes it to attack any coronavirus infection.`,
      bgColor: "#2196F3",
      type: "titleImageTextPost",
    },
  ],
  covaxin: [
    {
      title: "What is covaxin?",
      image: `${process.env.REACT_APP_CLOUDINARY_URL}/covaxin_okdldc.jpg`,
      text: `COVAXIN, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). It is a 2-dose vaccination regimen given 28 days apart.`,
      bgColor: "#2196F3",
      type: "titleImageTextPost",
    },
    {
      title: "How it works?",
      image: `${process.env.REACT_APP_CLOUDINARY_URL}/covaxin_okdldc.jpg`,
      text: `This vaccine is developed with Whole-Virion Inactivated Vero Cell-derived technology. They contain inactivated viruses, which can not infect a person but still can teach the immune system to prepare a defence mechanism against the active virus.`,
      bgColor: "#2196F3",
      type: "titleImageTextPost",
    },
  ],
  sputnikv: [
    {
      title: "What is Sputnik V?",
      image: `${process.env.REACT_APP_CLOUDINARY_URL}/sputnik5_lg6rnz.jpg`,
      text: `Sputnik V (Russian: Спутник V) is a viral vector vaccine for COVID-19. Sputnik V is an adenovirus viral vector vaccine.Emergency mass-distribution of the vaccine began in December 2020.`,
      bgColor: "#2196F3",
      type: "titleImageTextPost",
    },
    {
      title: "How it works?",
      image: `${process.env.REACT_APP_CLOUDINARY_URL}/sputnik5_lg6rnz.jpg`,
      text: `It is a viral two-vector vaccine based on two human adenoviruses – a common cold virus – containing the gene that encodes the full-length spike protein (S) of SARS-CoV-2 to stimulate an immune response. The recombinant adenovirus types 26 and 5 are both used as vectors in the vaccine. Both of them are administered into the deltoid muscle: the Ad26-based vaccine is used on the first day and the Ad5 vaccine is used on the 21st day to boost immune response.`,
      bgColor: "#2196F3",
      type: "titleImageTextPost",
    },
  ],
  "pfizer–biontech": [
    {
      title: "What is Pfizer–BioNTech Vaccine?",
      image: `${process.env.REACT_APP_CLOUDINARY_URL}/Pfizer-BioNTech_llp0og.jpg`,
      text: `The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine. Vaccination requires two doses given three weeks apart.`,
      bgColor: "#2196F3",
      type: "titleImageTextPost",
    },
    {
      title: "How it works?",
      image: `${process.env.REACT_APP_CLOUDINARY_URL}/Pfizer-BioNTech_llp0og.jpg`,
      text: `The BioNTech technology for the vaccine is based on use of nucleoside-modified mRNA (modRNA) which encodes a mutated form of the full-length spike protein found on the surface of the SARS-CoV-2 virus, triggering an immune response against infection by the virus protein.`,
      bgColor: "#2196F3",
      type: "titleImageTextPost",
    },
  ],
  moderna: [
    {
      title: "What is Moderna Vaccine?",
      image: `${process.env.REACT_APP_CLOUDINARY_URL}/Pfizer-BioNTech_llp0og.jpg`,
      text: `The Moderna COVID‑19 vaccine, codenamed mRNA-1273, is a COVID-19 vaccine developed by Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA). It is designed to be administered as two 0.5 mL doses given by intramuscular injection at an interval of four weeks apart.`,
      bgColor: "#2196F3",
      type: "titleImageTextPost",
    },
    {
      title: "How it works?",
      image: `${process.env.REACT_APP_CLOUDINARY_URL}/Pfizer-BioNTech_llp0og.jpg`,
      text: `It is an RNA vaccine composed of nucleoside-modified mRNA (modRNA) encoding a spike protein of SARS-CoV-2, which is encapsulated in lipid nanoparticles. This mRNA then reprograms the cells to prompt immune responses`,
      bgColor: "#2196F3",
      type: "titleImageTextPost",
    },
  ],
  sinopharm: [
    {
      title: "What is Sinopharm Vaccine?",
      image: `${process.env.REACT_APP_CLOUDINARY_URL}/Sinopharm_xghn4j.jpg`,
      text: `Sinopharm BBIBP-CorV, also known as the Sinopharm COVID-19 vaccine, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. It is being used in vaccination campaigns by certain countries in Asia, Africa,South America and Europe`,
      bgColor: "#2196F3",
      type: "titleImageTextPost",
    },
    {
      title: "How it works?",
      image: `${process.env.REACT_APP_CLOUDINARY_URL}/Sinopharm_xghn4j.jpg`,
      text: `Sinopharm BBIBP-CorV COVID-19 is an inactivated vaccine made of virus particles grown in culture and lack disease-producing capability. The BBIBP-CorV vaccine works by teaching the immune system to make antibodies against the SARS-CoV-2 beta coronavirus.`,
      bgColor: "#2196F3",
      type: "titleImageTextPost",
    },
  ],
};

export default storiesData;
